authors

• Jones, Katherine E
• Knopman, David S
• Petersen, Ronald C
• Graff-Radford, Jonathan
• Vassilaki, Maria
• Aakre, Jeremiah A
• Castillo, Anna M
• Ramanan, Vijay K
• Kremers, Walter K
• Jack, Clifford R
• Vemuri, Prashanthi
• Schwarz, Christopher G
• Lowe, Val J

publication date

• February 17, 2025

published in

• The journal of prevention of Alzheimer's disease  Journal

has subject area

• Aged
• Aged, 80 and over
• Alzheimer Disease
• Antibodies, Monoclonal, Humanized
• Brain
• Cognitive Aging
• Cognitive Dysfunction
• Eligibility Determination
• Female
• Humans
• Male
• Middle Aged
• Patient Selection
• Positron-Emission Tomography
• tau Proteins

Keywords

• Clinical trials
• Donanemab
• Eligibility

Digital Object Identifier (DOI)

• https://doi.org/10.1016/j.tjpad.2025.100088

PubMed ID

• 39966022

start page

end page

volume

• 12

issue

• 4